Doktor axborotnomasi 2022, №3.1 (107)


Subject of the article

COVID-19 КАСАЛЛИГИ ВА ПОСТ-COVID-СИНДРОМ МУАММОСИ (83-85)

Authors

Н. Х. Мавлонов, С. Х. Фозилов

Institution

Бухоро давлат тиббиёт институти, Бухоро, Ўзбекистон

Abstract

Мақолада COVID-19 касаллиги ва пост-COVID-синдром тўғрисидаги маълумотлар келтирилган. Ўтказилган тадқиқотлар натижалари умумлаштирилган ҳолда ўрганилган. Мақолада касалликнинг давомийлиги ва замонавий талқин қилиш муаммоларига изоҳ берилган.

Key words

COVID-19, белгилар, классификация, ташҳислаш.

Literature

1. А. Ш. Каскабаева, Р. И. Алибекова, А. С. Ботабаева, Ж. М. Уразалина, Д. К. Муздубаев Портрет пожилого пациента «COVID-19 и почки» // Вестник врача, № 3.1 (96), 2020. С.156-159. 2. Х. Т. Мирахмедова, Г. Х. Исканова, С. Ш. Эгамова Предикторы повреждения почек при COVID-19 // Вест-ник врача, № 3.1 (96), 2020. С.63-66. 3. Carfì A, Bernabei R, et al. Persistent Symptoms in Patients After Acute COVID-19. JAMA.2020; 324 (6): 603–605. DOI: 10.1001/jama.2020.12603. 4. Davis H.E., Assaf G.S., McCorkell L. Characterizing Long COVID in an International Cohort: 7 Months of Symp-toms and Their Impact. Available at: https://www.medrаxiv.org/content/10.1101/2020.12.24.20248802v2 12. 5. Fernandez-de-Las-Penas C., Palacios-Cena D., Gomez-Mayordomo V. (2021) Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): An integrative classification. Int. J. Environ. Res. Pub-lic Health, vol. 18, no 5, p. 2621. doi: 10.3390/ijerph18052621. 6. Greenhalgh T., Knight M., A’Court M. (2020) Management of post-acute COVID-19 in primary care. BMJ, vol. 370, m3026. doi: 10.1136/bmj.m3026. 7. Havervall S., Rosell A., Phillipson M. (2021) Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA, vol. 325, no 19, pp. 2015–2016. doi: 10.1001/jama.2021.5612. 8. Huang C., Huang L., Wang Y. (2021) 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet, vol. 397, pp. 220–232. 9. Karaarslan F, Guneri FD, et al. Long COVID: rheumatolo- gic/mus culoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol [published online ahead of print, 2021 Oct 29]. 2021; 1-8. DOI: 10.1007/s10067-021-05942-x. 10. Mavlonov N.X. //Рrevalence of modifiable risk factors for chronic noncommunicable diseases in the elderly and senile population. ACADEMICIA An International Multidisciplinary Research Journal, January2021 Vol. 11, Is-sue 1, P. 1148–1154. Impact Factor=7.492 DOI:10.5958/2249-7137.2021.00178.6 pp. 587–594. 11. Pavli A., Theodoridou M., Maltezou H.C. (2021) Post-COVID syndrome: Incidence, clinical spectrum, and chal-lenges for primary healthcare professionals. Arch. Med. Res, S0188-4409(21)00081-3. doi: 10.1016/j.arcmed.2021.03.010. 12. Taquet M, Luciano S, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021; 8(2): 130-140. DOI: 10.1016/S2215-0366(20)30462-4 13. Writing Committee for the COMEBAC Study Group, Morin L., Savale L. (2021) Four-month clinical status of cohort of patients after hospitalization for COVID-19. JAMA, vol. 325, no 15, pp. 1525–1534. doi: 10.1001/jama.2021.3331.